Adderall Types: What's the Difference?
Adderall is a brand name for a medication commonly prescribed to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. It's a stimulant medication containing a combination of amphetamine and dextroamphetamine. There are several types of Adderall, which differ in their dosage strengths, formulation, and intended use.
IR vs. XR: What's the Difference?
The main difference between Adderall types is the release mechanism:
- Immediate Release (IR): Adderall IR tablets contain a mixture of amphetamine and dextroamphetamine and are designed to release the medication quickly, allowing for fast onset of action.
- Extended Release (XR): Adderall XR capsules contain a mixture of amphetamine and dextroamphetamine in a special coating that releases the medication over a longer period, providing a gradual increase in concentration.
Dosage Strengths:
Adderall and Adderall XR are available in various dosage strengths, including:
- 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 18mg, 20mg, 25mg, and 30mg of amphetamine + dextroamphetamine for Adderall IR
- 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg of amphetamine + dextroamphetamine for Adderall XR
Adderall LA: Long-Acting Formulation
Adderall LA is a long-acting formulation designed for individuals with ADHD who require a slow release of the medication over an extended period. It's available in 8mg, 10mg, 12mg, 15mg, and 18mg dosages.
Adderall vs. Adderall XR for Addiction Treatment:
While Adderall and Adderall XR are both used to treat ADHD and narcolepsy, they may have different applications in addiction treatment. Some studies suggest that the extended-release formulation of Adderall may be more effective in maintaining abstinence from certain substances.
Patent and Generics:
The patent for Adderall (amphetamine and dextroamphetamine) expired in 2015, and generic versions of the medication are available. However, the patent for the specific formulation of Adderall XR is still in effect, and generic versions may not be identical in terms of release mechanism and composition.
Regulatory Status:
Both Adderall and Adderall XR are classified as Schedule II controlled substances by the US FDA, indicating that they have a high potential for abuse and dependence.
Clinical Data:
Studies have demonstrated the efficacy of Adderall and Adderall XR in treating ADHD symptoms, with some research indicating that the extended-release formulation may be more effective in maintaining attention and reducing symptoms over time.
Patient Concerns:
Common side effects of Adderall and Adderall XR include insomnia, anxiety, and increased heart rate. Patients should discuss potential risks and benefits with their healthcare provider.
Sources:
[1] https://www.drugpatentwatch.com/Drug/Amphetamine-and-dextroamphetamine [Adderall]
[2] https://www.drugbank.ca/drugs/DB00221 [Adderall]
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751332/ [Adderall XR for ADHD]